Diagnostic Imaging Pathways - Screening for Breast Cancer in High Risk Women

References

1. National Breast Cancer Centre. Advice about familial aspects of breast cancer and epithelial ovarian cancer – A guide for health professional (February 2006). Click here to view reference
2. Saslow D, Boetes C, Burke W et al. American Cancer Society Guidelines for Breast Screening with MRI as Adjunct to Mammagraphy. CA Cancer J Clin 2007;57:75-89. (Guideline) Click here to view reference
3. McDonald S, Saslow D, Alciati M. Performance and Reporting of Clinical Breast Examination: A Review of the Literature. CA Cancer J Clin 2004;54:345-361 (Level II Evidence) Click here to view reference
4. Thistlethwaite J. Clinical Breast Examination for asymptomatic women. Aust Fam Phy 2007;36:145-149 (Review Article)
5. Gotzsche P, Nielsen M . Screening for breast cancer with mammography. Coch Database Sys Rev 2006;Oct 18 (Level 1 Evidence) Click here to view reference
6. Shapiro S, Venet W, Strax P et al. Ten to fourteen year effect of screening on breast cancer mortality. J Nat Cancer Inst 1982;69:349-55 (Level II Evidence). Click here to view reference
7. Bjurstan N, Bjorneld L, Warwick J et al. The Gothenburg Breast Screening Trial. Cancer 2003;97(10):2387-2396.
8. Moss S, Cuckle H, Evan A et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 year's follow-up: a randomized controlled trial Lancet 2006;368:2053-2060 (Level II Evidence) Click here to view reference
9. Hadden W. Recommendations for the surveillance of young women at increased risk for breast cancer. Aust Radiol 2007;51:1-11 (Review Article)
10. Buchberger W, Niehoff A, Obrist et al. Clinically and Mammographically Occult Breast Lesions: Detection and Classification with High-Resolution Sonography. Sem in Ultrasound CT MRI 2000:21(4):325-336 (Level II Evidence) Click here to view reference
11. Greene T, Cocilove C, Estabrook A et al. A single institution review of new breast malignancies identified solely by sonography. J Am Coll Surg 2006;203(6):894-898 (Level IV Evidence)
12. Kriege M, Brekelmans, Boetes C et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. NEJM 2004;351:427-437 (Level II Evidence) Click here to view reference
13. Boetes C, Veltman J. Screening women at increased risk with MRI. Cancer Imag 2005;5:S10-S15 (Review Article)
14. Warner E, Plewes D, Hill K et al. Surveillance of BRCA1 and BRCA2 mutation carriers with Magnetic Resonance Imaging, Ultrasound, Mammography and Clinical Breast Examination. JAMA 2004;292:1317-1325 (Level II Evidence) Click here to view reference
15. Kuhl C, Schrading S, Leutner C et al. Mammography, Breast Ultrasound and Magnetic Resonance Imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-8476 (Level II Evidence) Click here to view reference
16. Leach M, Boggis C, Dixon et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study. Lancet 2005;365:1769-1778 (Level II Evidence) Click here to view reference
17. Lehman C, Blume J, Weatherall P et al. Screening women at High Risk for Breast Cancer with Mamommography and Magnetic Resonance. Cancer 2005;105:1898-1905 (level II Evidence) Click here to view reference
18. Lehman C. Role of MRI in screening women at high risk of breast cancer. J of MRI 2006;24:964-970 (Review article)

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.